Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
|
BM |
|
Health House International Ltd
ASX:HHI
|
AU |
|
Kimball Electronics Inc
NASDAQ:KE
|
US |
|
B
|
Boombit SA
WSE:BBT
|
PL |
|
ANZ Group Holdings Ltd
OTC:ANZGF
|
AU |
|
Apogee Enterprises Inc
NASDAQ:APOG
|
US |
|
W
|
Wuxi Hodgen Technology Co Ltd
SZSE:300279
|
CN |
|
Hellofresh SE
XETRA:HFG
|
DE |
|
Z
|
Zinitix Co Ltd
KOSDAQ:303030
|
KR |
|
GDI Integrated Facility Services Inc
TSX:GDI
|
CA |
|
E
|
Electra Ltd
TASE:ELTR
|
IL |
|
S
|
SMU SA
SGO:SMU
|
CL |
|
Funding Circle Holdings PLC
LSE:FCH
|
UK |
|
Gentrack Group Ltd
NZX:GTK
|
NZ |
|
S
|
Sigma Lithium Corp
NASDAQ:SGML
|
CA |
|
G
|
GoLogiq Inc
OTC:GOLQ
|
US |
|
Celyad Oncology SA
XBRU:CYAD
|
BE |
|
B
|
Bualuang Office Leasehold Real Estate Investment Trust
SET:B-WORK
|
TH |
|
Roche Holding AG
OTC:RHHBY
|
CH |
|
Waste Management Inc
NYSE:WM
|
US |
|
H
|
HDFC Asset Management Company Ltd
NSE:HDFCAMC
|
IN |
|
Mazagon Dock Shipbuilders Ltd
NSE:MAZDOCK
|
IN |
|
Hercules SA Fabrica De Talheres
BOVESPA:HETA4
|
BR |
|
Longitech Smart Energy Holding Ltd
HKEX:1281
|
CN |
Present Value Calculation
This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.
DCF Model
Base Case Scenario
Switching the operating model will discard any changes made to the current valuation.
DCF Operating Model
DCF Value Calculation
This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.
Present Value to DCF Value
Capital Structure
DCF Capital Structure
Valuation Analysis
Sensitivity Analysis
DCF Value Sensitivity Analysis
Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.
DCF Sensitivity Analysis
DCF Financials
Financials used in DCF Calculation
DCF Financials
What is the DCF value of one KNSA stock?
Estimated DCF Value of one
KNSA
stock is
hidden
USD.
Compared to the current market price of 48.13 USD, the stock is
hidden
.
The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.
How was the DCF Value calculated?
1. Present Value Calculation.
Utilizing the DCF operating model, Kiniksa Pharmaceuticals Ltd's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at
hidden
.
2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of hidden per share.
